IMRICOR MEDICAL SYSTEMS INC.
ASX:IMRHealth Care Equipment & ServicesToday’s holders own 89.7% of what they think they own, once every option and right converts.
Share count grew 33% in 24 months; 2 cash raises in 24 months; options/rights overhang 12% of shares
IMRICOR MEDICAL SYSTEMS INC.'s ordinary share count grew 32.7% between September 2024 and September 2026, its latest share-count filing, to 359M shares. The company raised capital twice in the period for total disclosed proceeds of A$130.0M, most recently a A$60.0M placement in May 2026. Options and rights on issue could convert into 41M new shares, equal to 11.5% of the current share count, none of which are in the money at the current share price; the nearest expiry date is not disclosed as no filing on record states an expiry date for these securities. The company has more than 4 quarters of funding at the recent spend rate. No proposed securities issues are currently pending.
Quick answers · 4
When did IMR last raise capital?
The last capital raise in Imricor Medical Systems's filings is Placement of $60.0M announced 4 May 2026, one of 2 cash raises in 24 months.
How much placement capacity does IMR have left?
About 33% of the 15% placement capacity left, about 67% used in 12 months (estimate). Under ASX Listing Rule 7.1 a company may place up to 15% of its shares in 12 months without shareholder approval.
How many options and rights does IMR have outstanding?
Unexercised options and rights equal 11.5% of Imricor Medical Systems's shares on issue.
How much has IMR's share count grown?
Imricor Medical Systems has 358.7M shares on issue as at 28 Oct 2026, up 32.7% over 24 months according to its Appendix 2A filings.
Shares on issue — last 2 years
Cash runway
Issuance timeline
Latest 5 filings (Appendix 2AThe form a company lodges to have new securities quoted on the ASX. It restates how many of each class are on issue. quoted issues, 3G unquoted, 3H cancellations)
| Date | Form | Security | On issue, per this filing | Source |
|---|---|---|---|---|
| 13 Oct 2026 | 3H · cancellation | IMR : CDI 1:1 US PERSON PROHIBITED EXCLUDING QIB | 358.7M | Appendix 3H |
| 12 Oct 2026 | 3G · unquoted | IMR : CDI 1:1 US PERSON PROHIBITED EXCLUDING QIB | 358.7M | Appendix 3G |
| 18 Sept 2026 | 2A · quoted issue | IMR : CDI 1:1 US PERSON PROHIBITED EXCLUDING QIB | 358.7M | Appendix 2A |
| 14 July 2026 | 3G · unquoted | IMR : CDI 1:1 US PERSON PROHIBITED EXCLUDING QIB | 358.5M | Appendix 3G |
| 13 July 2026 | 2A · quoted issue | IMR : CDI 1:1 US PERSON PROHIBITED EXCLUDING QIB | 358.5M | Appendix 2A |
Securities on issue over time
Ordinary shares and every option and rights class, month by month over two years. The top edge is the fully diluted count.
Capital raises
2 cash raises in the last 24 months · 1 in the last 12 months
Forward supply
Every dated event on record that could add securities to the register — option expiries to their stated dates and proposed issues over the next 18 months, on one timeline.
Placement capacity
How much stock a company can place without asking holders. Listing Rule 7.1 / 7.1ARule 7.1 lets a company issue up to 15% of its shares in 12 months without a shareholder vote. Rule 7.1A adds 10% for smaller companies whose holders approve it. allows 15% of ordinary securities in any 12 months, and every Appendix 3BNotice that a company proposes to issue new securities, such as a placement. The securities are not on issue until a later filing confirms it. states how much of it an issue uses.
Pending proposed issues
Options & convertible securities
No option supply on record carries an exercise price to pay, so no share price switches any of it on. All 41.3M of it converts on something else — a hurdle that may never be met, or terms the filing does not price.
| Code | Security | Type | Exercise price | Expiry | On issue | Source |
|---|---|---|---|---|---|---|
| IMRAU | Warrants | Price-triggered, no exercise price stated | — | — | 5.1M | Filing |
| IMRAJ | Options | Price-triggered, no exercise price stated | — | — | 36.2M | Filing |
“Nil” is a stated nil exercise price: nothing is paid to convert. An em dash means the filing names no exercise price at all. Security is read from the filing’s own class description; an em dash there means the description is not one this table labels. One row is one security class, at the number stated in the most recent quotation application that restated it — linked, and dated, in the last column. For what expires soon across other listed companies, see the options expiry calendar.
- IMRATconvertible notes213 Oct 2026 Appendix 2A
Director dealings
| Date | Director | Type | Shares | Options | Other | Value | Source |
|---|---|---|---|---|---|---|---|
| 14 May 2026 | Mr Aldo Denti | Other | 23k | — | — | — | 3Y notice |
| 14 May 2026 | Mr Mark Tibbles | Other | 34k | — | — | — | 3Y notice |
| 14 May 2026 | Mr Peter McGregor | Other | — | — | — | — | 3Y notice |
| 14 May 2026 | Mr Steve Wedan | Other | — | 423k | — | — | 3Y notice |
| 14 May 2026 | Ms Anita Messal | Other | 27k | — | — | — | 3Y notice |
Ownership
Latest announcements
Headlines link to the source PDFs on the ASX announcements platform. Data as of 28 Oct 2026.